HealthcareMRR2

  Microfluidic Devices Market 2022 Microfluidic device, simply put, is a technology which enables the integration of several medical tests on one chip. This has turned into a crucial technology for parallelization, miniaturization, industrialization, and integration of numerous tests in diagnostics, biological research, and drug development. The  Global  Microfluidic Devices Market   is predicted to touch USD 14,296.04 Million at a  19.70% CAGR  over the forecast period, as per the latest Market Research Future (MRFR) report. Various factors are propelling the microfluidic devices market growth. These factors, according to the latest MRFR report, include the rise in demand for point of care testing products, growing demand in proteomics and genomics, miniaturization of chips, liquid biopsies, personalized medicine, and organ-on-a-chip. Additional factors pushing market growth include rising use in drug delivery systems, especially inhalers and insulin pumps and growing awareness of the

  Artificial insemination Market Artificial insemination involves depositing sperm into the uterus. In vitro fertilization (IVF) involves extracting the patient's egg cells to be fertilized in a lab. The resultant embryo is then transferred to the uterus. The reimbursement of these techniques is interrelated. Artificial insemination costs hundreds of dollars, while IVF costs thousands. Most of the countries in North America and Europe have a high adoption of treatments related to fertility. The number of cycles of artificial insemination covered differs depending on the country. Global  Artificial Insemination Market  is expected to register a  CAGR of 8.56%  during the forecast period and is expected to hit  USD 3,409.75 Million by 2027 . The province of New Brunswick, Canada, allows individuals to claim up to 50 percent of eligible costs incurred for IVF or IUI and related drugs, up to a maximum of USD 5,000. In France, up to four cycles of ART in women up to the age of 45 are re

  COVID Testing Kit Market According to the latest data, there were 86,827 new cases on 16 May 2020 and 7,215,102 new cases on 8 June 2020, globally. Due to such increasing numbers of cases, there is a growing demand for more COVID-19 testing kits and devices, hence driving the market growth. Global  COVID Testing Kit Market  is expected to have a market value of  USD 97,903.2 Million  by 2027. Major Key Players: MRFR recognizes the following companies as the Key Players in the Global COVID Testing Kit— Abbott (US), BioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Chembio Diagnostic Systems, Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), GenMark (US), Henry Schein, Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen (Germany), Siemens AG (Germany), Guangzhou Wondfo Biotech (China), Robert Bosch GmbH (Germany), Cellex (US), Mayo Clinic Laboratories (US), Mount Sinai Laboratory (US), Zhejiang Orient Gene Biotech Co., Ltd. (China), Dynamiker Biotech

  Gene Therapy Market Gene therapy is a technique in which a piece of DNA is incorporated into the cell via a vector. The key players are investing in the manufacturing of cell and gene therapy treatments due to its target specificity. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets. According to MRFR analysis, the global  gene therapy market  is expected to register a  CAGR of 40.7%  during the forecast period and was valued at USD 524 million in 2018. The growth of the global gene therapy market is attributed to various factors such as robust product pipeline, increasing investment by key players, and high prevalence of target diseases and demand for innovative medication. However, the high cost of product development and stringent regulatory policies are expected to curb the growth of the global gene therapy market. The global gene therapy market is currently dominated by several market players. The

  CBD Market As per CBD market analysts, the global market is anticipated to witness growth owing to the factors such as the growing research & development as well as financial support by various private and government organizations. However, the market will face challenges and restraints due to adverse effects associated with cannabis and stringent government policies during the forecast period. The global  CBD market  will grow at a  CAGR of 125.58%  during the forecast period. The market for CBD is set to reach US$22,07,162.54 million by 2026. Rising occurrence of chronic diseases in the CBD market will support the growth. As per market analysts, the market-based companies will face certain challenges during the forecast period 2019 to 2026. The market research report provides in-depth analysis of the application, end user, forms, product, routes of administration, and source segments. The market research report presents factors such as complications regarding side effects that

  Healthcare Cloud Computing Market The volume of digital data in healthcare centers has multiplied over the years owing to changes in payment modes, increasing patient pool, etc.  Advances in technology and increasing healthcare expenditure have further catalyzed the growth of the market.  The Global  Healthcare Cloud Computing Market  is experiencing increasing traction owing to the rising uptake of cloud computing in small, medium, and large healthcare setups, worldwide. The need for the deployment of cloud computing and cutting-edge analytical tools has intensified, enhancing operational efficiency. These factors subsequently escalate the market on the global platform. According to Market Research Future (MRFR), the global healthcare cloud computing market is expected to expand exponentially by 2023. In its recently published analysis, MRFR also asserts that during the forecast period (2018 – 2023) the market would register a phenomenal CAGR. The market value has increased tremendo

  Remdesivir Market Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. The growth of the global Remdesivir (COVID 19 )  market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19 ) , are expected to restrain the growth of the global Remdesivir (COVID 19 )  market. According to MRFR analysis, Global  Remdesivir (COVID 19) Market  is expected to register a  CAGR of 31.2%  during the forecast period of 2020 to 2027 and reach  USD 10,119.99 Million by 2027. Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hu

  Cardiac Biomarkers Market The key factors that drive the cardiac biomarkers market are the increasing prevalence of cardiovascular diseases and lifestyle diseases, increasing prevalence of cardiovascular diseases and lifestyle diseases, increase in demand for disease-specific treatment & research in which cardiac biomarkers are used, technological advancements in cardiac biomarkers, and favorable government initiatives to create awareness related to cardiovascular diseases. However, a lack of awareness among people is expected to hamper market growth. The global  cardiac biomarkers market  is expected to register a  CAGR of 16.36%  during the forecast period and is expected to hit  USD 4236.02 Million by 2027 . There are a number of factors that impact the growth of the cardiac biomarkers market. Some of the key factors include a rise in demand for diagnostic and testing of various cardiovascular diseases, development and advancement in cardiac biomarkers, and growth in the patie

  Thalassemia Treatment Market Thalassemia is an inherited blood disorder that is characterized by inadequate hemoglobin and fewer red blood cells in the body than normal. Hemoglobin is the substance in red blood cells that allows them to carry oxygen. The inadequate hemoglobin and fewer red blood cells of thalassemia may cause anemia. According to MRFR analysis,  Thalassemia Treatment Market   is expected to register a  CAGR of 10.4%  during the forecast period and was valued at  USD 1890.4 Million in 2018. The growth of the Global Thalassemia Treatment Market is driven by various factors such as rising incidence of thalassemia, increasing pipeline drugs in thalassemia, rise in awareness regarding available treatment options for the treatment of thalassemia, growing public awareness related to preventive care and rise in demand for improved curative gene therapy. However, stringent regulatory policies and high treatment costs are expected to curb the growth of the global thalassemia t

  Healthcare Cyber Security Market Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime. Healthcare Cyber Security Market  is expected to register a  CAGR of   11.82%  during the forecast period, with a market value of  USD 16,393.15 Million till 2025. The primary vital factors driving the market growth are the increasing cyberattacks in the healthcare industry, regulatory and government norms to protect patient data, and the growing implementation of mobile device applications and platforms and increased use of Internet of things (IoT) devices in the healthcare sector. However, factors such as lack of adoption of updated software and

  Uveitis Treatment Market Uveitis is an inflammation that occurs in the uvea. It is found in people aged between 20 to 50. Based on the origin of inflammation, uveitis categories in major three types, namely, anterior uveitis, posterior uveitis, and intermediate uveitis. The growth of the global uveitis treatment market is determined by numerous factors such as increasing research & development (R&D) expenditure, rising prevalence of uveitis and continuous product launches. However, side-effect related to corticosteroid drugs is projected to restrain the growth of the market during the forecast period. According to MRFR analysis,  Uveitis Treatment Market   is expected to register a  CAGR of 5.6%  during the forecast period and was valued at  USD 534.6 million in 2018 . The global uveitis treatment market is currently dominated by several market players. The key players are involved in expansion, product launches, and strategic collaborations to strengthen their market positio

  Durable Medical Equipment Market Durable Medical Equipment or home medical equipment provides therapeutic benefits to patients. They are easy to use and does not need any special skill or training thus can easily be managed by a caretaker or a family member of the patient. Increasing per capita income, healthcare expenditure and aging population in Middle East and Africa are driving the DME market’s growth. The Middle-East and Africa  Durable Medical Equipment Market  has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. The Middle East and Africa healthcare sector is growing by 10% annually and it comprise 2% of the total global healthcare expenditure. Huge Investment in R&D by DME manufacturers are leading to more innovative product development. Developing infrastructure, government initiatives, extended insurance coverage and increasing awareness are major drivers of this market. Growing number

  Molecular Diagnostics Market The market for molecular diagnostics is set to reach US$16.32 billion by 2025. As per Global Market, the global market is anticipated to witness growth owing to the factors such as technological advancements in molecular diagnostics as well as the increasing prevalence of hospital-acquired infections. However, the market will face challenges and restraints due to the stringency of molecular diagnostics regulations and the restrictive nature of the regulatory framework during the forecast period. The global  molecular diagnostics market , during the forecast period, will register growth at a  CAGR of 8.57%. The detection of numerous diseases in the market is set to play a key role in determining the growth potential during 2016 to 2025 years. Analysts have also studied the molecular diagnostics industry to understand potential threats and challenges the molecular diagnostics industry companies could face. Although the molecular diagnostics industry is pois